Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

High throughput formulation: strategies for rapid development of stable protein products.

Nayar R, Manning MC.

Pharm Biotechnol. 2002;13:177-98. Review. No abstract available.

PMID:
11987752
2.

Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.

Jorgensen L, Hostrup S, Moeller EH, Grohganz H.

Expert Opin Drug Deliv. 2009 Nov;6(11):1219-30. doi: 10.1517/17425240903199143. Review.

PMID:
19678792
3.

Dosage form design and development.

Allen LV Jr.

Clin Ther. 2008 Nov;30(11):2102-11. doi: 10.1016/j.clinthera.2008.11.015. Review.

PMID:
19108798
4.

Formulation and manufacturability of biologics.

Shire SJ.

Curr Opin Biotechnol. 2009 Dec;20(6):708-14. doi: 10.1016/j.copbio.2009.10.006. Epub 2009 Oct 31. Review.

PMID:
19880308
5.

High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.

Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR.

Adv Drug Deliv Rev. 2004 Feb 23;56(3):275-300. Review.

PMID:
14962582
6.

Formulation strategies for sustained release of proteins.

Lewis AL, Illum L.

Ther Deliv. 2010 Sep;1(3):457-79. Review.

PMID:
22816145
7.

The stability factor: importance in formulation development.

Krishnamurthy R, Manning MC.

Curr Pharm Biotechnol. 2002 Dec;3(4):361-71. Review.

PMID:
12463418
8.

Protein formulation and fill-finish operations.

Patro SY, Freund E, Chang BS.

Biotechnol Annu Rev. 2002;8:55-84. Review.

PMID:
12436915
9.

Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.

Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB.

Adv Drug Deliv Rev. 2011 Oct;63(13):1118-59. doi: 10.1016/j.addr.2011.07.006. Epub 2011 Jul 29. Review.

PMID:
21855584
10.

Recent applications of Chemical Imaging to pharmaceutical process monitoring and quality control.

Gowen AA, O'Donnell CP, Cullen PJ, Bell SE.

Eur J Pharm Biopharm. 2008 May;69(1):10-22. doi: 10.1016/j.ejpb.2007.10.013. Epub 2007 Nov 1. Review.

PMID:
18164926
11.

Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.

Volkin DB, Sanyal G, Burke CJ, Middaugh CR.

Pharm Biotechnol. 2002;14:1-46. Review. No abstract available.

PMID:
12189723
12.

Drug-like property concepts in pharmaceutical design.

Di L, Kerns EH, Carter GT.

Curr Pharm Des. 2009;15(19):2184-94. Review.

PMID:
19601822
14.

Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review.

Gendrin C, Roggo Y, Collet C.

J Pharm Biomed Anal. 2008 Nov 4;48(3):533-53. doi: 10.1016/j.jpba.2008.08.014. Epub 2008 Aug 22. Review.

PMID:
18819769
15.

Visual analytics in the pharmaceutical industry.

Saffer JD, Burnett VL, Chen G, van der Spek P.

IEEE Comput Graph Appl. 2004 Sep-Oct;24(5):10-5. Review. No abstract available.

PMID:
15628094
16.

Pediatric drug development: formulation considerations.

Ali AA, Charoo NA, Abdallah DB.

Drug Dev Ind Pharm. 2014 Oct;40(10):1283-99. doi: 10.3109/03639045.2013.850713. Epub 2014 Jan 31. Review.

PMID:
24483293
17.

Drug delivery strategies for poorly water-soluble drugs.

Fahr A, Liu X.

Expert Opin Drug Deliv. 2007 Jul;4(4):403-16. Review.

PMID:
17683253
18.

Promises of biomarkers in drug development--a reality check.

Marrer E, Dieterle F.

Chem Biol Drug Des. 2007 Jun;69(6):381-94. Review.

PMID:
17581232
19.

Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process.

Trivedi NR, Rajan MG, Johnson JR, Shukla AJ.

Crit Rev Ther Drug Carrier Syst. 2007;24(1):1-40. Review.

PMID:
17430098
20.

Fundamentals of freeze-drying.

Nail SL, Jiang S, Chongprasert S, Knopp SA.

Pharm Biotechnol. 2002;14:281-360. Review.

PMID:
12189727

Supplemental Content

Support Center